Search the Newsreel

Wall Street Zen Downgrades FinWise Bancorp (NASDAQ:FINW) to Strong Sell

Wall Street Zen has downgraded FinWise Bancorp (NASDAQ:FINW) from a "sell" to a "strong sell" rating. This downgrade comes as FinWise shares opened near their 52-week low and below key moving averages, following a quarter where earnings per share missed analyst expectations. Despite the …

Edgewise Therapeutics CMO Joanne Donovan sells $412,703 in stock

Joanne M. Donovan, CMO of Edgewise Therapeutics, sold 9,441 shares totaling $412,703 in August 2026, with a portion covering tax obligations from RSU vesting and the remainder under a Rule 10b5-1 plan. These sales followed her acquisition of shares from RSU vesting and new …

Edgewise Therapeutics CSO Alan Russell sells $258k in stock

Edgewise Therapeutics' Chief Scientific Officer, Alan J. Russell, sold 5,901 shares of company stock for $258,042, primarily to cover tax obligations from RSU vesting. Following the sale, he still holds 31,466 shares directly, along with additional RSUs and stock options. This transaction follows the …

Edgewise Therapeutics (NASDAQ:EWTX) CEO Kevin Koch Sells 17,971 Shares of Stock

Edgewise Therapeutics (NASDAQ:EWTX) CMO Sells 6,522 Shares

Edgewise Therapeutics CMO Joanne Donovan recently sold 6,522 shares of EWTX stock for $285,989.70 to cover tax withholding obligations on vested equity awards, reducing her holdings by 36.1%. Despite this insider sale and a quarterly earnings miss, the company's shares rose 2.3%, and analysts …

Insider Selling: Edgewise Therapeutics (NASDAQ:EWTX) Insider Sells 5,901 Shares

Edgewise Therapeutics (NASDAQ:EWTX) insider Alan Russell sold 5,901 shares of the company's stock on August 12th, 2026, totaling approximately $258,051. This sale was conducted to cover tax withholding obligations related to vested equity awards. Despite this insider selling, analysts maintain a "Moderate Buy" consensus …

Edgewise Therapeutics (EWTX) CSO gets 97,500-share equity awards, sells shares for taxes

Edgewise Therapeutics' Chief Scientific Officer, Alan J. Russell, reported equity transactions on August 12, 2026, which included exercising Restricted Stock Units and selling 5,901 shares to cover tax withholding obligations. Additionally, Russell received new equity awards comprising 32,500 RSUs and a stock option for …

Edgewise Therapeutics (NASDAQ:EWTX) General Counsel Sells $219,801.12 in Stock

Edgewise Therapeutics General Counsel John Moore sold 5,016 shares of EWTX stock worth $219,801.12 to cover tax withholding obligations from vested equity awards, reducing his direct ownership by 22.08%. The company's stock is trading near its 52-week high, and despite missing recent earnings expectations, …

Edgewise Therapeutics (EWTX) grants CFO 24,375 RSUs and 48,750-share option

Edgewise Therapeutics (EWTX) has granted its CFO, Michael Nofi, 24,375 Restricted Stock Units (RSUs) and an option for 48,750 shares of common stock. The RSUs vest in four equal annual installments starting August 12, 2027, and the stock options vest monthly over 48 months …

RA Capital’s 7.8% Edgewise Therapeutics (EWTX) stake totals 8.39M shares

RA Capital Management, L.P. and its affiliated parties have reported a 7.8% stake in Edgewise Therapeutics, Inc. (EWTX), totaling 8,392,730 shares of common stock. This ownership is held by RA Capital Healthcare Fund, L.P., with RA Capital having shared voting and dispositive power over …

Edgewise Therapeutics (EWTX) grants 50,000 RSUs and 100,000 options to CBO

Edgewise Therapeutics reported that its Chief Business Officer, Derakhshan Behrad, received equity awards comprising 50,000 Restricted Stock Units (RSUs) and a stock option for 100,000 shares. Behrad also had 5,781 and 7,500 RSUs convert into common stock on August 12, 2026, and subsequently sold …

Robbins LLP Urges WSE Stockholders Who Lost Money Investing in Wise Group plc to Contact the Firm for Information About Leading the Class Action

Robbins LLP is reminding investors that a securities class action has been filed against Wise Group plc (NASDAQ: WSE) for allegedly making false statements regarding its anti-money laundering compliance and regulatory risks. The lawsuit claims that Wise failed to disclose material regulatory issues, including …

Edgewise Therapeutics (EWTX): Baker Bros. discloses 3.4% ownership in Schedule 13G/A

Wise Group (WSE): Orbis and Allan Gray disclose 5.5% beneficial stake in Class A shares

Orbis Investment Management Ltd and Allan Gray Australia Pty Limited have jointly reported a beneficial ownership of 5.5% in Wise Group plc's Class A ordinary shares, totaling 56,634,516 shares. Orbis holds sole voting and dispositive power over 56,530,693 shares, while Allan Gray Australia holds …

Lost Money on Wise Group plc (WSE)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

The Gross Law Firm has issued a notice to shareholders of Wise Group plc (NASDAQ: WSE) to join a class action lawsuit. The lawsuit alleges that Wise Group plc made materially false and misleading statements regarding its regulatory risks and anti-money laundering efforts between …

REG - Wise Group PLC - Holding(s) in Company

Skaala Investments OÜ has notified Wise Group PLC of a change in their major holdings, crossing the threshold on August 11, 2026. Their total voting rights in Wise Group PLC now stand at 6.656%, down from a previous notification of 8.7162%. This notification details …

Envision Greenwise Sets Auditor Reappointment and Fee Range Ahead of AGM

China Healthwise Sets August Board Meeting to Review Interim Results and Dividend

Bank of America Corp DE Decreases Position in Edgewise Therapeutics, Inc. $EWTX

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Wise Group plc Investors to Secure Counsel ...

Rosen Law Firm is encouraging investors of Wise Group plc (NASDAQ: WSE) to secure legal counsel as they approach the September 29, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Wise Group plc made false or misleading statements …

Kaplan Fox Urges Wise Group plc (NASDAQ: WSE) Investors to Contact the Firm Before the Deadline on September 29, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Wise Group plc (NASDAQ: WSE) on behalf of investors who purchased securities between May 11, 2026, and July 23, 2026. The lawsuit stems from a Reuters article alleging that Wise's shares fell …

Edgewise Therapeutics, Inc. SEC Filing (Aug 13, 2026)

Edgewise Therapeutics, Inc. (EWTX) filed a Form 144 with the SEC on August 13, 2026, indicating a proposed sale of securities. The filing details the sale of 2,919 shares of common stock with an aggregate market value of $127,151.64 by an individual who acquired …

Bragar Eagel & Squire, P.C. Urges Wise Group plc (WSE)

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Wise Group plc (WSE) on behalf of investors who purchased securities between May 11, 2026, and July 23, 2026. The lawsuit alleges that Wise Group plc understated its regulatory risks related to …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Wise Group plc of Class Action Lawsuit and Upcoming Deadlines - WSE

Pomerantz LLP has filed a class action lawsuit against Wise Group plc (NASDAQ: WSE), advising investors who incurred losses to contact them. The lawsuit alleges that Wise and its officers engaged in securities fraud, citing reports of a money laundering investigation in Brussels and …

Likewise Group CEO Discusses Fundraising, Capacity Growth And Revenue Ambitions

Wasatch Advisors LP Sells 99,915 Shares of FinWise Bancorp $FINW

Wise Ally Sets August Board Meeting to Approve Interim 2026 Results

CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics?

FinWise Bancorp (FINW) Q2 2026 Earnings Call Transcript

Wise Group (NasdaqGS:WSE) Aktienprognose & Analystenprognosen

Wise Group (NasdaqGS:WSE) is projected to see annual earnings and revenue growth of 11.4% and 14.1% respectively, with EPS expected to grow by 15.1% per year and return on equity estimated at 26.4% in three years. Recent updates include earnings guidance for fiscal year …

Finwise Bancorp Q2 2026: Revenue $33.98M, EPS $0.15— 10-Q Summary

Finwise Bancorp reported its Q2 2026 results, showing a significant increase in total interest income to $33.98M, a 72.1% rise from the previous year, driven by rapid loan origination growth and increased credit program activity. However, net income and diluted EPS decreased by 48.0% …

MarketWise (MKTW) board opts for annual say-on-pay votes after 2026 meeting

MarketWise, Inc. (MKTW) has decided to hold annual "say-on-pay" advisory votes for stockholders following its 2026 Annual Meeting. This decision was made in response to shareholder preferences, where a plurality of votes favored a one-year frequency for executive compensation votes. The company anticipates holding …

Deadline Alert: Wise Group plc (WSE) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP has issued a deadline alert for investors of Wise Group plc (WSE) who incurred losses between May 11, 2026, and July 23, 2026. The firm urges affected shareholders to contact them regarding a class-action lawsuit alleging securities fraud, …